Programme Details

Announcement Brochure

ABUS Workshop Brochure

ABUS Workshop Brochure

                                           
0830 - 0900Conquering Challenging Breast Lesions - An Expert ViewIan Ellis
0900 - 0930Diagnostic Agreement in Breast Pathology: Can We Improve?Kimberly Allison
0930 - 1000Question-and-Answer Session

                                                                           
1000 - 1010Opening Performance
1010 - 1015Welcome Address by Organising ChairAngela Chong
1015 - 1020Welcome Remark by ABDA PresidentPhilip Iau
1020 - 1030Opening Speech by Guest-of-Honour     Mr Chan Heng Kee
Permanent Secretary
Ministry of Health
1030 - 1100Plenary Lecture - Breast Cancer: Culture Matters!Cynthia Chou,

                                           
1130 - 1200Near Misses in Breast PathologyIan Ellis
1200 - 1230Papillary Breast Lesions - A Practical ApproachTan Puay Hoon
1230 - 1300Question-and-Answer Session

                                           
1400 - 1430Updates in Breast Cancer Pathology Best Practices: Be a "Diagnostic Oncologist"Kimberly Allison
1430 - 1500Breast Pathology EQA - Performance Issues and Digital ApplicationIan Ellis
1500 - 1530Question-and-Answer Session

                                           
1600 - 1630Updates in Breast Cancer Pathology Best Practices: Be a "Diagnostic Oncologist"Ian Ellis
1630 - 1700Breast Pathology EQA - Performance Issues and Digital ApplicationKimberly Allison
1700 - 1730Question-and-Answer Session

Venue: Faber Peak Address: 109 Mount Faber Road, Singapore 099203

1400 - 1530
Challenges in Imaging I

                                                           
1400 - 1425Missed Breast Cancers : Why and How to Avoid ? Eliza Fung Po Yan
1425 - 1450Breast Screening in Rural MalaysiaShantini Arasaratnam
1450 - 1515In the Land of Mordor Where the Shadows Lie: The Hard-to-See LesionsTan Soo See, Susanna
1515 - 1530Question-and-Answer Session

                                                           
1600 - 1425Challenges in Mammographic Positioning in Diagnostic and Biopsy Cases: The SGH ExperienceLily Lai
1625 - 1650Approach to Diagnosis of Challenging CasesMalai Muttarak
1650 - 1715Ultrasound of the Axilla: What We Have to KnowDaniel Makes
1715 - 1730Question-and-Answer Session

Venue: Faber Peak Address: 109 Mount Faber Road, Singapore 099203

1600 - 1730
Oncology Case Discussion

Rameysh D. Mahmood, Tan Sing Huang, Tan Yah Yuen

Venue: Faber Peak Address: 109 Mount Faber Road, Singapore 099203

0830 - 1100
Plenary Lecture III - Young Breast Cancer

                                                                         
0830 - 0900Pathology LectureKimberly Allison
0900 - 0930Radiological Challenges in the Diagnosis of Breast Cancer in Young WomenJuliana Ho Teng Swan
0930 - 1000Barriers to Early Detection of Breast CancerYip Chin Har
1000 -1030Genetic Counselling and Fertility PreservationElaine Lim
1030 - 1100Question-and-Answer Session

1130 - 1155 CDK4/6 Inhibitors Changing Practice in Breast Cancer – Present & Future Jack Chan
1155 - 1220 Newer Targets and recent updates in the Treatment of Advanced Breast Cancer Elaine Lim
1220 - 1245 Role of Surgery in MBC Philip Iau
1245 - 1300 Question-and-Answer Session

1400 - 1425 Approach to Adjuvant Treatment Planninig for ER+ HER2- Breast Cancer Patients with Genomic Profiling Ong Kong Wee
1425 - 1450 Extended LD flap Reconstruction for Early Breast Cancer Phuong Viet The Tran
1450 - 1515 Updates and Recommendations for Post Mastectomy Radiation Vicky Koh
1515 - 1530 Question-and-Answer Session

1600 - 1625 Pitfalls in Core Biopsies of the Breast Gary Tse
1625 - 1650 Histology of Breast Lesions Showing Microcalcifications Rin Yamaguci
1650 - 1715 Recent Updates in Management of DCIS Chan Ching Wan
1715 - 1730 Question-and-Answer Session

1130 - 1300
DCIS Symposium

1130 - 1155 Detection of DCIS Lee Yien Sien
1155 - 1220 Imaging Work Up of the Patient with DCIS Thida Win
1220 - 1245 Image-guided Intervention of the Patient with DCIS Teo Sze Yiun
1245 - 1300 Question-and-Answer Session

1400 - 1425 Refining the Diagnosis of Breast Fibroepithelial Lesions on Core Biopsies Using a Novel Genomic Panel – Preliminary Findings Sim Yi Rong
1625 - 1650 Genomics of Fibroadenomas Tan Puay Hoon
1450 - 1515 Challenges in Interpretation of Breast Fibroepithelial Lesions on Core Biopsies Tan Yong Cheng
1515 - 1530 Question-and-Answer Session

The Journey and Questions along the way Kimberly Allison
Panel Discussion Kimberly Allison, Pathologist
Esther Chuwa, Surgeon Elaine Lim, Oncologist
Rameysh D. Mahmood, Radiologist Tan May Leng Mabel, Breast Nurse
Richard Yeo, Radiation Oncology Yu Su Ling, Gynaecologist

1330 - 1530
ABUS Session I, by GE Healthcare

http://whiteearthdesign.co.uk/shop/?paged=1 Invenia™ ABUS Lecture and Workshop
About 4 in 10 women have dense breasts, but typically this is only discovered during a mammogram. Moreover, women with dense breasts are 4 to 6 times more likely to develop breast cancer. Dense tissue can further hide cancers on a mammogram.
GE’s ABUS is the first FDA-approved ultrasound technology for screening women with dense breasts. Multiple studies have shown that the addition of 3D Automated Breast Ultrasound (ABUS) to screening mammography results in a significant increase in invasive cancer detection with a nominal insignificant decrease in specificity. Click here to learn more about the ABUS image display and image manipulation options.
Dr. Monica Saini is Chief Medical Officer at the Institute of Women’s Imaging and is affiliated with multiple hospitals in the area, including Christus St. Vincent Regional Medical Center and Los Alamos Medical Center. She received her medical degree from Rush Medical College and has been in practice between 11-20 years. She is a doctor at Christus St. Vincent Regional Medical Center and at Los Alamos Medical Center specializing in Radiology. Before settling in New Mexico, the Chicago-raised physician completed a breast imaging fellowship at the University of Washington in Seattle. Dr Saini has been an active part of introducing ABUS technology and workflow into various types of medical centres across the United States. During this session, she will undertake a literature review and discuss the techniques and pros and cons of using ABUS. This will be complemented by a hands-on workshop and discussion. “As a sub-specialized breast imaging physician and former nurse, I have dedicated my professional life to not only find breast cancer but to address the breast and the woman as one integrated whole.” – Dr. Monica Saini Come join us to experience the ABUS during this hands-on workshop and learn more about the latest developments in breast imaging. For further enquiries or to schedule a demonstration at your facility, you can speak with our GE colleagues who will be present at the workshop and will be happy to assist you. In the meantime, you can also contact Murni at murni.murni@ge.com *As there are limited places available, please register your attendance.
1330 - 1430 1. Pros and Cons of ABUS with Literature Review
2. Technique of ABUS Video Presentation
1430 - 1530 Hands-on Session

Dr Monica Saini

go here Invenia™ ABUS Lecture and Workshop
About 4 in 10 women have dense breasts, but typically this is only discovered during a mammogram. Moreover, women with dense breasts are 4 to 6 times more likely to develop breast cancer. Dense tissue can further hide cancers on a mammogram.
GE’s ABUS is the first FDA-approved ultrasound technology for screening women with dense breasts. Multiple studies have shown that the addition of 3D Automated Breast Ultrasound (ABUS) to screening mammography results in a significant increase in invasive cancer detection with a nominal insignificant decrease in specificity. Click here to learn more about the ABUS image display and image manipulation options.
Dr. Monica Saini is Chief Medical Officer at the Institute of Women’s Imaging and is affiliated with multiple hospitals in the area, including Christus St. Vincent Regional Medical Center and Los Alamos Medical Center. She received her medical degree from Rush Medical College and has been in practice between 11-20 years. She is a doctor at Christus St. Vincent Regional Medical Center and at Los Alamos Medical Center specializing in Radiology. Before settling in New Mexico, the Chicago-raised physician completed a breast imaging fellowship at the University of Washington in Seattle. Dr Saini has been an active part of introducing ABUS technology and workflow into various types of medical centres across the United States. During this session, she will undertake a literature review and discuss the techniques and pros and cons of using ABUS. This will be complemented by a hands-on workshop and discussion. “As a sub-specialized breast imaging physician and former nurse, I have dedicated my professional life to not only find breast cancer but to address the breast and the woman as one integrated whole.” – Dr. Monica Saini Come join us to experience the ABUS during this hands-on workshop and learn more about the latest developments in breast imaging. For further enquiries or to schedule a demonstration at your facility, you can speak with our GE colleagues who will be present at the workshop and will be happy to assist you. In the meantime, you can also contact Murni at murni.murni@ge.com *As there are limited places available, please register your attendance.
1330 - 1430 1. Pros and Cons of ABUS with Literature Review
2. Technique of ABUS Video Presentation
1430 - 1530 Hands-on Session

Dr Monica Saini
1130 - 1300
Molecular Workshop Session I

1130 - 1135 Welcome and Opening Address Tan Puay Hoon
1135 - 1145 Course Outline and Introduction to HER2 FISH Workshop Alvin Lim
1145 - 1225 HER2 FISH: Proposed Revisions to Guidelines Kimberly Allison)
1225 - 1300 FISH techniques Josephine Ho

1400 - 1445 Interpretation and Scoring Guidelines (ASCO 2013) Lim Tse Hui
1445 - 1530 Practical Session: Pre-test Challenge / Interactive Session Yvette Yeap, Klara What and FISH team

1600 - 1645 Practical Session: Post-test Challenge Yvette Yeap, Klara What and FISH team
1645 - 1715 Question-and-Answer Session
1715 - 1730 Lab Visit (Optional depending on time)
1730 - 1745 Closing Remarks Dr Angela Chong